Selective HDAC inhibition for the disruption of latent HIV-1 infection.
Selective histone deacetylase (HDAC) inhibitors have emerged as a potential anti-latency therapy for persistent human immunodeficiency virus type 1 (HIV-1) infection. We utilized a combination of small molecule inhibitors and short hairpin (sh)RNA-mediated gene knockdown strategies to delineate the...
Main Authors: | Kirston M Barton, Nancie M Archin, Kara S Keedy, Amy S Espeseth, Yan-ling Zhang, Jennifer Gale, Florence F Wagner, Edward B Holson, David M Margolis |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4138023?pdf=render |
Similar Items
-
New Frontiers in Measuring and Characterizing the HIV Reservoir
by: Shane D. Falcinelli, et al.
Published: (2019-12-01) -
Vorinostat Renders the Replication-Competent Latent Reservoir of Human Immunodeficiency Virus (HIV) Vulnerable to Clearance by CD8 T Cells
by: Julia A. Sung, et al.
Published: (2017-09-01) -
Peripheral Vγ9Vδ2 T Cells Are a Novel Reservoir of Latent HIV Infection.
by: Natalia Soriano-Sarabia, et al.
Published: (2015-10-01) -
Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylation
by: Alberto Bosque, et al.
Published: (2017-01-01) -
HIV-1 in the latent reservoir is largely sensitive to circulating T cells
by: J. Warren, et al.
Published: (2019-12-01)